Key facts
- It has raised $310K; the latest was Accelerator/Incubator ($200K) in May 2025.
- Notable investors include Antler, QAI Ventures, DayOne Accelerator.
- Status: Privately Held (backing).
Investors
3- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for DryLabz
- ·The full record, as it builds
Funding rounds
No funding rounds for DryLabz are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About DryLabz
Developer of a healthtech company intended to offer advanced diagnostics for patients. The company integrated in-vitro diagnostic tests with medical records, data science and AI, enabling patients to receive personalized care without data resulting in fragmented decisions.
- Sector
- Healthcare
- HQ
- Basel, Switzerland
- Founded
- 2025
- Employees
- 2
- Website
- drylabz.com/
- Ownership
- Privately Held (backing)
DryLabz doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in DryLabz shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on DryLabz in its N-PORT filings yet. We sweep new filings monthly.